日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report

直肠癌新辅助放化疗期间由EB病毒和巨细胞病毒感染引起的噬血细胞综合征:病例报告

Kanesada, Kou; Yoshimatsu, Kazuhiko; Yano, Shuya; Higashida, Masaharu; Okada, Toshimasa; Endo, Shunji; Fujiwara, Yoshinori; Ueno, Tomio

ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer.

ADAR1 高表达的肿瘤相关巨噬细胞可诱导耐药性,是结直肠癌的治疗靶点

Umeda Hibiki, Shigeyasu Kunitoshi, Takahashi Toshiaki, Moriwake Kazuya, Kondo Yoshitaka, Yoshida Kazuhiro, Takeda Sho, Yano Shuya, Matsumi Yuki, Kishimoto Hiroyuki, Fuji Tomokazu, Yasui Kazuya, Yamamoto Hideki, Takagi Kosei, Kayano Masashi, Michiue Hiroyuki, Nakamura Keiichiro, Mori Yoshiko, Teraishi Fuminori, Tazawa Hiroshi, Umeda Yuzo, Kagawa Shunsuke, Goel Ajay, Fujiwara Toshiyoshi

Risk factors for postoperative pneumonia in older adults aged ≥ 80 years with gastric cancer

80岁及以上老年胃癌患者术后肺炎的危险因素

Endo, Shunji; Higashida, Masaharu; Fujiwara, Yoshinori; Furuya, Kei; Yano, Shuya; Okada, Toshimasa; Yoshimatsu, Kazuhiko; Ueno, Tomio

Rare Case of Gut-associated Lymphoid Tissue Carcinoma in the Sigmoid Colon of a Very Elderly Patient: A Case Report

一例罕见的发生于高龄患者乙状结肠的肠道相关淋巴组织癌:病例报告

Kanesada, Kou; Yoshimatsu, Kazuhiko; Ito, Yoshitomo; Yano, Shuya; Hori, Masaaki; Higashida, Masaharu; Okada, Toshimasa; Endo, Shunji; Fujiwara, Yoshinori; Fujimoto, Yasuto; Shiomi, Tatsushi; Ueno, Tomio

Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles

循环游离DNA甲基化模式作为非侵入性生物标志物,无需参考原发部位突变谱即可监测结直肠癌治疗效果。

Yasui, Kazuya; Toshima, Toshiaki; Inada, Ryo; Umeda, Yuzo; Yano, Shuya; Tanioka, Hiroaki; Nyuya, Akihiro; Fujiwara, Toshiyoshi; Yamada, Takeshi; Naomoto, Yoshio; Goel, Ajay; Nagasaka, Takeshi

Prognostic factors for gastric cancer patients aged ≥ 85 years

85岁及以上胃癌患者的预后因素

Endo, Shunji; Higashida, Masaharu; Furuya, Kei; Yano, Shuya; Okada, Toshimasa; Yoshimatsu, Kazuhiko; Fujiwara, Yoshinori; Ueno, Tomio

Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation

雷莫芦单抗用于二线晚期结直肠癌治疗:一项关于治疗结果和肝窦血小板聚集的研究

Kimura, Keisuke; Katata, Yosuke; Umeda, Yuzo; Tanaka, Takehiro; Yano, Shuya; Yoshida, Kazuhiro; Fujiwara, Toshiyoshi; Mori, Yoshiko; Yamada, Takeshi; Nagasaka, Takeshi

ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer

ADAR1是一种有前景的结直肠癌肝转移瘤切除术后残余肝脏复发风险分层生物标志物。

Hata, Nanako; Shigeyasu, Kunitoshi; Umeda, Yuzo; Yano, Shuya; Takeda, Sho; Yoshida, Kazuhiro; Fuji, Tomokazu; Yoshida, Ryuichi; Yasui, Kazuya; Umeda, Hibiki; Takahashi, Toshiaki; Kondo, Yoshitaka; Kishimoto, Hiroyuki; Mori, Yoshiko; Teraishi, Fuminori; Yamamoto, Hideki; Michiue, Hiroyuki; Nakamura, Keiichiro; Tazawa, Hiroshi; Fujiwara, Toshiyoshi

Neutrophil‑to‑lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer

每次化疗方案前的中性粒细胞与淋巴细胞比值可预测不可切除胃癌患者的临床预后

Tanioka, Hiroaki; Okawaki, Makoto; Yano, Shuya; Yoshimitsu, Tomomi; Tokuda, Kikue; Nyuya, Akihiro; Yamaguchi, Yoshiyuki; Nagasaka, Takeshi

Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma

调节性T细胞诱导抑制性免疫微环境,并促进肝内胆管癌的淋巴结转移。

Konishi, Daisuke; Umeda, Yuzo; Yoshida, Kazuhiro; Shigeyasu, Kunitoshi; Yano, Shuya; Toji, Tomohiro; Takeda, Sho; Yoshida, Ryuichi; Yasui, Kazuya; Fuji, Tomokazu; Matsumoto, Kazuyuki; Kishimoto, Hiroyuki; Michiue, Hiroyuki; Teraishi, Fuminori; Kato, Hironari; Tazawa, Hiroshi; Yanai, Hiroyuki; Yagi, Takahito; Goel, Ajay; Fujiwara, Toshiyoshi